4.7 Article

Liver secretin receptor predicts portoenterostomy outcomes and liver injury in biliary atresia

Journal

SCIENTIFIC REPORTS
Volume 12, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41598-022-11140-9

Keywords

-

Funding

  1. Sigrid Juselius Foundation
  2. Finnish Pediatric Research Foundation
  3. Finska Lakaresallskapet
  4. Helsinki University Hospital Fund

Ask authors/readers for more resources

This study investigates the utility of secretin receptor (SCTR) as a potential biomarker for predicting native liver survival and clearance of jaundice after portoenterostomy (PE) surgery in patients with biliary atresia (BA). The results show that higher expression of SCTR is associated with lower 5-year native liver survival and clearance of jaundice after PE. SCTR expression also correlates with liver fibrosis, ductular reaction, and markers of fibrosis and cholangiocytes. Therefore, SCTR may serve as a promising prognostic marker for PE outcomes and liver injury in BA.
Biliary atresia (BA) is a chronic neonatal cholangiopathy characterized by fibroinflammatory bile duct damage. Reliable biomarkers for predicting native liver survival (NLS) following portoenterostomy (PE) surgery are lacking. Herein we explore the utility of 22 preidentified profibrotic molecules closely connected to ductular reaction (DR) and prevailing after successful PE (SPE), in predicting PE outcomes and liver injury. We used qPCR and immunohistochemistry in a BA cohort including liver samples obtained at PE (n = 53) and during postoperative follow-up after SPE (n = 25). Of the 13 genes over-expressed in relation to cholestatic age-matched controls at PE, only secretin receptor (SCTR) expression predicted cumulative 5-year NLS and clearance of jaundice. Patients in the highest SCTR expression tertile showed 34-55% lower NLS than other groups at 1-5 years after PE (P = 0.006-0.04 for each year). SCTR expression was also significantly lower [42 (24-63) vs 75 (39-107) fold, P = 0.015] among those who normalized their serum bilirubin after PE. Liver SCTR expression localized in cholangiocytes and correlated positively with liver fibrosis, DR, and transcriptional markers of fibrosis (ACTA2) and cholangiocytes (KRT7, KRT19) both at PE and after SPE. SCTR is a promising prognostic marker for PE outcomes and associates with liver injury in BA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available